336 fundamentals
An in-depth look to HEPION PHARMACEUTICALS INC operating, investing, and financing activities
336 free cash flow for Q4 23 is -8.16 M EUR. For 2023, 336 free cash flow was -37.06 M EUR and operating cash flow was -37.05 M EUR.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM